BamSEC and AlphaSense Join Forces
Learn More

Cassava Sciences Inc.

NASDAQ: SAVA    
Share price (12/23/24): $2.41    
Market cap (12/23/24): $116 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K/A 9 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 8 pages Consulting Agreement
12/34/56
EX-10.1
from 8-K 1 page Amendment to Employment Agreement
12/34/56
EX-10.3
from 10-Q 3 pages Non-Employee Director Compensation Program
12/34/56
EX-10.2
from 10-Q 13 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Would Likely Cause Competitive Harm if Publicly Disclosed. Such Portions Are Marked as Indicated With Brackets (“[***]”) Below. Cassava Sciences, Inc. 2020 Cash Incentive Bonus Plan [As Amended by the Board of Directors Effective March 16, 2023]
12/34/56
EX-10.1
from 8-K 35 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 5 pages Personal and Confidential 
12/34/56
EX-10.1
from 10-Q 1 page  Amendment No. 1 to the Cassava Sciences, Inc. 2018 Omnibus Incentive Plan
12/34/56
EX-10.1
from 10-K 15 pages Indemnification Agreement
12/34/56
EX-10.4
from 10-Q 81 pages  Agreement of Sale and Purchase  Between  Dwf IV Lakewood, LP, a Delaware Limited Partnership  “Seller”  and  Cassava Sciences, Inc., a Delaware Corporation “Buyer”  With Escrow Instructions for  Heritage Title Company  “Escrow Agent” 
12/34/56
EX-10.3
from 10-Q 44 pages  Master Services Agreement
12/34/56
EX-10.1
from 8-K 18 pages  Master Services Agreement
12/34/56
EX-10.1
from 8-K 34 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 3 pages James W. Kupiec, MD Xxxx Xxxx  via Email: Xxx@gmail.com  Dear Jim:  on Behalf of Cassava Sciences, I Am Pleased to Extend You an Offer of Employment as Chief Clinical Development Officer, Initially Reporting to Me. This Letter Agreement and Its Enclosures Are Intended Set Forth the Terms and Conditions of Your New Employment.  Your Base Salary Will Be Three Hundred and Seventy-Five Thousand Dollars ($375,000) Per Calendar Year, Paid Bi-Monthly. on Your Start Date You Will Be Added as a Participant in Cassava Science’s 2020 Cash Incentive Bonus Plan.  Your Full-Time Start Date Is Monday, January 4, 2021. 
12/34/56
EX-10.1
from 8-K 5 pages Recitals
12/34/56
EX-10.1
from 8-K 13 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Would Likely Cause Competitive Harm if Publicly Disclosed. Such Portions Are Marked as Indicated With Brackets (“[***]”) Below. Cassava Sciences, Inc. 2020 Cash Incentive Bonus Plan
12/34/56
EX-10.1
from 8-K 2 pages Pain Therapeutics, Inc
12/34/56
EX-10.1
from 8-K 3 pages Pain Therapeutics, Inc. 
12/34/56
EX-10.2
from 8-K 9 pages Strictly Confidential  Pain Therapeutics, Inc. 7801 N. Capital of Texas Highway, Suite 260 Austin, Tx 78731  Attn: Remi Barbier, President and Chief Executive Officer  Dear Mr. Barbier
12/34/56
EX-10.1
from 8-K 40 pages Securities Purchase Agreement
12/34/56